To view this email as a web page, click here.
October 16, 2019
 
Ticagrelor with Aspirin Effective as CAD and Diabetes Treatment
Researchers writing in the New England Journal of Medicine report that a combination treatment of ticagrelor and aspirin had led to improved cardiovascular disease outcomes in patients with stable coronary artery disease and diabetes mellitus.
Read more

Activity Trackers Work Best with Coaching
A comprehensive systematic review and meta-analysis of 36 randomized clinical trials shows that using activity trackers produces some health benefit, but primarily when combined with coaching.
Read more

Type 2 diabetes drug dapagliflozin reduces the risk of worsening heart failure
The type 2 diabetes drug dapagliflozin reduces the risk for worsening heart failure or death from cardiovascular disease among individuals with heart failure and reduced ejection fraction, whether or not they have diabetes, shows a study published in the New England Journal of Medicine.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.